Elevated Granzyme B in cytotoxic lymphocytes is a signature of immune activation in hemophagocytic lymphohistiocytosis

Patients with hemophagocytic lymphohistiocytosis (HLH) exhibit immune hyper-activation as a consequence of genetic defects in secretory granule proteins of cytotoxic T lymphocytes (CTL) and natural killer (NK) cells. Murine models of HLH demonstrate significant activation of CTL as central to the di...

Full description

Bibliographic Details
Main Authors: Sabine eMellor-Heineke, Joyce eVillanueva, Michael B Jordan, Rebecca eMarsh, Kejian eZhang, Jack eBleesing, Alexandra (Lisa) H Filipovich, Kimberly A Risma
Format: Article
Language:English
Published: Frontiers Media S.A. 2013-03-01
Series:Frontiers in Immunology
Subjects:
CTL
Online Access:http://journal.frontiersin.org/Journal/10.3389/fimmu.2013.00072/full
id doaj-87292267522e4d849b1d07b88a36c417
record_format Article
spelling doaj-87292267522e4d849b1d07b88a36c4172020-11-24T23:07:18ZengFrontiers Media S.A.Frontiers in Immunology1664-32242013-03-01410.3389/fimmu.2013.0007242529Elevated Granzyme B in cytotoxic lymphocytes is a signature of immune activation in hemophagocytic lymphohistiocytosisSabine eMellor-Heineke0Joyce eVillanueva1Michael B Jordan2Rebecca eMarsh3Kejian eZhang4Jack eBleesing5Alexandra (Lisa) H Filipovich6Kimberly A Risma7Cincinnati Childrens Hospital Medical CenterCincinnati Childrens Hospital Medical CenterCincinnati Childrens Hospital Medical CenterCincinnati Childrens Hospital Medical CenterCincinnati Childrens Hospital Medical CenterCincinnati Childrens Hospital Medical CenterCincinnati Childrens Hospital Medical CenterCincinnati Childrens Hospital Medical CenterPatients with hemophagocytic lymphohistiocytosis (HLH) exhibit immune hyper-activation as a consequence of genetic defects in secretory granule proteins of cytotoxic T lymphocytes (CTL) and natural killer (NK) cells. Murine models of HLH demonstrate significant activation of CTL as central to the disease pathogenesis, but evaluation of CTL and NK activation in children with HLH or inflammatory conditions is not well described. CD8 T cells only express granzyme B (GrB) following stimulation and differentiation into CTL; therefore, we reasoned that GrB expression may serve as a signature of CTL activation. It is unknown whether human NK cells are similarly activated in vivo, as marked by increased granule proteins. Perforin and GrB levels are measured in both CTL and NK cells by flow cytometry to diagnose perforin deficiency. We retrospectively compared GrB expression in blood samples from 130 children with clinically suspected and/or genetically defined HLH to age-matched controls. As predicted, CD8 expressing GrB cells were increased in HLH, regardless of genetic etiology. Remarkably, the GrB protein content also increased in NK cells in patients with HLH and decreased following immunosuppressive therapy. This suggests that in vivo activation of NK cells occurs in hyper-inflammatory conditions. We conclude that increased detection of GrB in CTL and NK are an immune signature for lymphocyte activation in HLH, irrespective of genetic subtype and may also be a useful measure of immune activation in other related conditions.http://journal.frontiersin.org/Journal/10.3389/fimmu.2013.00072/fullClinical ImmunologyCTLNatural Killer cellsHemophagocytic lymphohistiocytosis (HLH)granzyme B
collection DOAJ
language English
format Article
sources DOAJ
author Sabine eMellor-Heineke
Joyce eVillanueva
Michael B Jordan
Rebecca eMarsh
Kejian eZhang
Jack eBleesing
Alexandra (Lisa) H Filipovich
Kimberly A Risma
spellingShingle Sabine eMellor-Heineke
Joyce eVillanueva
Michael B Jordan
Rebecca eMarsh
Kejian eZhang
Jack eBleesing
Alexandra (Lisa) H Filipovich
Kimberly A Risma
Elevated Granzyme B in cytotoxic lymphocytes is a signature of immune activation in hemophagocytic lymphohistiocytosis
Frontiers in Immunology
Clinical Immunology
CTL
Natural Killer cells
Hemophagocytic lymphohistiocytosis (HLH)
granzyme B
author_facet Sabine eMellor-Heineke
Joyce eVillanueva
Michael B Jordan
Rebecca eMarsh
Kejian eZhang
Jack eBleesing
Alexandra (Lisa) H Filipovich
Kimberly A Risma
author_sort Sabine eMellor-Heineke
title Elevated Granzyme B in cytotoxic lymphocytes is a signature of immune activation in hemophagocytic lymphohistiocytosis
title_short Elevated Granzyme B in cytotoxic lymphocytes is a signature of immune activation in hemophagocytic lymphohistiocytosis
title_full Elevated Granzyme B in cytotoxic lymphocytes is a signature of immune activation in hemophagocytic lymphohistiocytosis
title_fullStr Elevated Granzyme B in cytotoxic lymphocytes is a signature of immune activation in hemophagocytic lymphohistiocytosis
title_full_unstemmed Elevated Granzyme B in cytotoxic lymphocytes is a signature of immune activation in hemophagocytic lymphohistiocytosis
title_sort elevated granzyme b in cytotoxic lymphocytes is a signature of immune activation in hemophagocytic lymphohistiocytosis
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2013-03-01
description Patients with hemophagocytic lymphohistiocytosis (HLH) exhibit immune hyper-activation as a consequence of genetic defects in secretory granule proteins of cytotoxic T lymphocytes (CTL) and natural killer (NK) cells. Murine models of HLH demonstrate significant activation of CTL as central to the disease pathogenesis, but evaluation of CTL and NK activation in children with HLH or inflammatory conditions is not well described. CD8 T cells only express granzyme B (GrB) following stimulation and differentiation into CTL; therefore, we reasoned that GrB expression may serve as a signature of CTL activation. It is unknown whether human NK cells are similarly activated in vivo, as marked by increased granule proteins. Perforin and GrB levels are measured in both CTL and NK cells by flow cytometry to diagnose perforin deficiency. We retrospectively compared GrB expression in blood samples from 130 children with clinically suspected and/or genetically defined HLH to age-matched controls. As predicted, CD8 expressing GrB cells were increased in HLH, regardless of genetic etiology. Remarkably, the GrB protein content also increased in NK cells in patients with HLH and decreased following immunosuppressive therapy. This suggests that in vivo activation of NK cells occurs in hyper-inflammatory conditions. We conclude that increased detection of GrB in CTL and NK are an immune signature for lymphocyte activation in HLH, irrespective of genetic subtype and may also be a useful measure of immune activation in other related conditions.
topic Clinical Immunology
CTL
Natural Killer cells
Hemophagocytic lymphohistiocytosis (HLH)
granzyme B
url http://journal.frontiersin.org/Journal/10.3389/fimmu.2013.00072/full
work_keys_str_mv AT sabineemellorheineke elevatedgranzymebincytotoxiclymphocytesisasignatureofimmuneactivationinhemophagocyticlymphohistiocytosis
AT joyceevillanueva elevatedgranzymebincytotoxiclymphocytesisasignatureofimmuneactivationinhemophagocyticlymphohistiocytosis
AT michaelbjordan elevatedgranzymebincytotoxiclymphocytesisasignatureofimmuneactivationinhemophagocyticlymphohistiocytosis
AT rebeccaemarsh elevatedgranzymebincytotoxiclymphocytesisasignatureofimmuneactivationinhemophagocyticlymphohistiocytosis
AT kejianezhang elevatedgranzymebincytotoxiclymphocytesisasignatureofimmuneactivationinhemophagocyticlymphohistiocytosis
AT jackebleesing elevatedgranzymebincytotoxiclymphocytesisasignatureofimmuneactivationinhemophagocyticlymphohistiocytosis
AT alexandralisahfilipovich elevatedgranzymebincytotoxiclymphocytesisasignatureofimmuneactivationinhemophagocyticlymphohistiocytosis
AT kimberlyarisma elevatedgranzymebincytotoxiclymphocytesisasignatureofimmuneactivationinhemophagocyticlymphohistiocytosis
_version_ 1725619034533134336